VolitionRX Limited VNRX
0.26
0.01
4.00%
as of 25 Sep
- Market cap
- $6.9M
- P/E
- 0.0×
Follow VNRX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
78.10% | 75.71% | 78.86% | 76.95% | |
| (239.21%) | (286.58%) | (280.21%) | (301.54%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
391.35% | 380.28% | 465.89% | 439.37% | |
Average Days of Receivables |
76.64 | 67.15 | 37.33 | 41.19 | |
Free Cash Flow per Share |
(3.65) | (3.70) | (3.02) | (2.14) | |
Free Cash Flow |
(19.77) | (19.77) | (20.76) | (19.58) | |
Capital Expenditures |
(0.15) | (0.09) | (0.10) | (0.02) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
78.02% | 83.43% | 108.38% | 99.03% | |
Accounts Receivable Turnover |
4.74 | 8.06 | 11.21 | 10.53 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
692.95% | 583.61% | 418.72% | 382.68% | |
Selling, General and Administrative Expense of Revenue |
949.19% | 774.85% | 555.76% | 507.52% | |
Share Based Compensation of Revenue |
149.33% | 100.71% | 61.36% | 38.21% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.86 | 0.84 | 0.84 | 0.76 | |
Depreciation/Fixed assets |
0.50 | 0.73 | 0.89 | 0.94 | |
Capex/Depreciation |
(0.07) | (0.03) | (0.03) | (0.01) | |
Revenue per Share |
0.27 | 0.32 | 0.36 | 0.27 | |
Operating CF per Share |
(3.63) | (3.68) | (3.00) | (2.14) | |
Capex per Share |
(0.03) | (0.02) | (0.01) | 0.00 | |
Capex to Sales |
0.10 | 0.05 | 0.04 | 0.01 | |
Net Profit Margin |
(1,554.22%) | (1,352.15%) | (997.45%) | (1,043.08%) |
Columns are period end dates